1
|
Bayuga S, Zeana C, Sahni J, Della-Latta P,
el-Sadr W and Larson E: Prevalence and antimicrobial patterns of
Acinetobacter baumannii on hands and nares of hospital
personnel and patients: the iceberg phenomenon again. Heart Lung.
31:382–390. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kumar A, Randhawa VS, Nirupam N, Rai Y and
Saili A: Risk factors for carbapenem-resistant Acinetobacter
baumanii blood stream infections in a neonatal intensive care
unit, Delhi, India. J Infect Dev Ctries. 8:1049–1054. 2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Chopra T, Marchaim D, Awali RA, Krishna A,
Johnson P, Tansek R, Chaudary K, Lephart P, Slim J, Hothi J, et al:
Epidemiology of bloodstream infections caused by Acinetobacter
baumannii and impact of drug resistance to both carbapenems and
ampicillin-sulbactam on clinical outcomes. Antimicrob Agents
Chemother. 57:6270–6275. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Dettori M, Piana A, Deriu MG, Lo Curto P,
Cossu A, Musumeci R, Cocuzza C, Astone V, Contu MA and Sotgiu G:
Outbreak of multidrug-resistant Acinetobacter baumannii in
an intensive care unit. New Microbiol. 37:185–191. 2014.PubMed/NCBI
|
5
|
Poirel L, Lebessi E, Castro M, Fèvre C,
Foustoukou M and Nordmann P: Nosocomial outbreak of
extended-spectrum beta-lactamase SHV-5-producing isolates of
Pseudomonas aeruginosa in Athens, Greece. Antimicrob Agents
Chemother. 48:2277–2279. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Pérez-Pérez FJ and Hanson ND: Detection of
plasmid-mediated AmpC beta-lactamase genes in clinical isolates by
using multiplex PCR. J Clin Microbiol. 40:2153–2162. 2002.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Bou G and Martínez-Beltrán J: Cloning,
nucleotide sequencing, and analysis of the gene encoding an AmpC
beta-lactamase in Acinetobacter baumannii. Antimicrob Agents
Chemother. 44:428–432. 2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu YN, Cao B, Wang H, Chen LA, She DY,
Zhao TM, Liang ZX, Sun TY, Li YM, Tong ZH, et al: Adult hospital
acquired pneumonia: A multicenter study on microbiology and
clinical characteristics of patients from 9 Chinese cities.
Zhonghua Jie He He Hu Xi Za Zhi. 35:739–746. 2012.(In Chinese).
PubMed/NCBI
|
9
|
Trottier V, Namias N, Pust DG, Nuwayhid Z,
Manning R, Marttos AC Jr, Dunham MB, Schulman CI and McKenney MG:
Outcomes of Acinetobacter baumannii infection in critically
ill surgical patients. Surg Infect (Larchmt). 8:437–443. 2007.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Lee YL, Chen YS, Toh HS, Huang CC, Liu YM,
Ho CM, Lu PL, Ko WC, Chen YH, Wang JH, et al: Antimicrobial
susceptibility of pathogens isolated from patients with complicated
intra-abdominal infections at five medical centers in Taiwan that
continuously participated in the Study for Monitoring Antimicrobial
Resistance Trends (SMART) from 2006 to 2010. Int J Antimicrob
Agents. 40 (Suppl):S29–S36. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Seral C, Gude MJ and Castillo FJ:
Emergence of plasmid mediated AmpC β-lactamasas: Origin,
importance, detection and therapeutical options. Rev Esp Quimioter.
25:89–99. 2012.(In Spanish). PubMed/NCBI
|
12
|
Zhu JM, Jiang RJ, Wu JL, Wu KL, Wang JM
and Kong HS: Study on the AmpC gene of Multiple drug resistant
Acinetobacter baumannii type ADC. Chin J Clin Infect Dis.
1:222–226. 2008.(In Chinese).
|
13
|
Niumsup PR, Boonkerd N, Tansawai U and
Tiloklurs M: Carbapenem-resistant Acinetobacter baumannii
producing OXA-23 in Thailand. Jpn J Infect Dis. 62:152–154.
2009.PubMed/NCBI
|
14
|
Malone L and Kwon DH:
Carbapenem-associated multidrug-resistant Acinetobacter
baumannii are sensitised by aztreonam in combination with
polyamines. Int J Antimicrob Agents. 41:70–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
García-Quintanilla M, Pulido MR,
López-Rojas R, Pachón J and McConnell MJ: Emerging therapies for
multidrug resistant Acinetobacter baumannii. Trends
Microbiol. 21:157–163. 2013. View Article : Google Scholar : PubMed/NCBI
|